What female sexual arousal difficulty actually is
Female sexual arousal disorder (FSAD) is a clinical term, but the presentations it covers are heterogeneous. Some women experience low or absent genital arousal (reduced lubrication, reduced clitoral engorgement) with or without subjective interest. Some experience normal or even high genital arousal but little or no subjective sense of feeling aroused — a phenomenon called "arousal non-concordance," documented extensively by Meredith Chivers and colleagues. Some experience desire but arousal blocks during the sexual encounter. And some experience low subjective arousal as a consequence of chronic pain (dyspareunia, vulvodynia) or medication effects (particularly SSRIs and hormonal contraception). The heterogeneity matters because the mechanism — and therefore the appropriate approach — differs substantially across these presentations. A research review that collapses them together will miss clinically important distinctions.
What the research shows for somatic and mindfulness-based approaches
The strongest evidence in this space comes from Lori Brotto's programme of randomised and controlled work on mindfulness-based sex therapy for women's desire and arousal difficulties. Consistent findings across multiple trials: mindfulness-based group interventions significantly reduce sex-related distress, improve subjective arousal, and in many cases improve sexual satisfaction — even where raw frequency of sex changes little. The mechanism appears to be attentional: mindfulness training reduces the self-monitoring and cognitive distraction that prevent subjective arousal from registering, regardless of whether genital arousal is physiologically present. Cynthia Meston's work on arousal non-concordance supports this framing — for women with high non-concordance, body-awareness training is a plausible intervention target because it builds the capacity to notice arousal signals that are genuinely present but not reaching conscious awareness. Sensate focus — which shares body-centred, non-goal-oriented attention principles with somatic and tantric approaches — is a component of most evidence-based sex therapy programmes for arousal difficulties globally.
Somatic approaches specifically — what they add
Somatic therapies for arousal difficulty go beyond mindfulness practice in integrating touch-based exploration, breath work, and structured body-mapping exercises. In the clinical literature, somatic approaches are most often referenced in the context of sexual trauma recovery — where body-based dissociation and arousal inhibition are common — and in the context of women with histories of pelvic pain or surgical intervention that has altered the body's sensory landscape. Peter Levine's somatic experiencing protocol has emerging evidence for trauma presentations including sexual trauma. Body-based approaches in general appear well-matched to arousal difficulty driven by dissociation, numbness, or the kind of arousal non-concordance that is amenable to attention training. The evidence at this level of specificity is largely from case series, practitioner clinical reports, and qualitative research rather than randomised trials.
Where the evidence is limited
Outside Brotto's specific mindfulness-based programme — which is the most rigorously studied — the evidence for individual somatic approaches to female arousal difficulty is thin. Most published work is non-randomised, has short follow-up, and involves self-selected samples. Research specifically on tantra-based or neo-tantric approaches to arousal is essentially absent from the peer-reviewed literature. The diagnostic heterogeneity of FSAD means that findings from one presentation (e.g., arousal difficulty in women with cancer history) do not transfer cleanly to another (e.g., arousal difficulty driven by hormonal contraception or relationship stress). Additionally, most trials focus on women without chronic pelvic pain — an important gap, since pain is a major cause of arousal inhibition and requires different management.
Medical causes — what must be ruled out first
Arousal difficulty can have medical causes that respond poorly to any psychological or somatic approach without concurrent medical treatment. SSRI antidepressants reduce genital arousal and subjective desire in a substantial proportion of users and are a frequent but often unrecognised contributor. Hormonal factors — oestrogen deficiency (postmenopause or post-hormonal-contraception), testosterone, and thyroid function — all influence arousal. Pelvic floor dysfunction and genital pain conditions can inhibit arousal through avoidance and pain anticipation. Any persistent arousal difficulty warrants medical evaluation — ideally with a sexual-medicine clinician or gynaecologist with an interest in sexual health — before beginning self-directed somatic or psychological work.
Disclaimer
This is educational content, not clinical advice. This review, authored by Sensorex, summarises published research areas and does not constitute a treatment recommendation for any individual. Female sexual arousal difficulty has multiple potential causes — medical, psychological, relational, and medication-related — that require individual clinical assessment. For a personal concern, see a qualified sexual-medicine clinician, gynaecologist, or credentialed sex therapist rather than self-treating from educational resources alone.